West Stokes graduate Matthew Grubb sits for a portrait with his National Honor Society stole and academic honor cord on June 5 at West Stokes High School in King. “I was very proud of her for ...

Health Canada approves Clearside Biomedical’s Xipere for suprachoroidal treatment for uveitic macular edema: Alpharetta, Georgia Friday, July 25, 2025, 18:00 Hrs [IST] Clearside ...

Most districts raised taxes between 2% and 5% for the next year, with Palmyra keeping its millage rate consistent.

Investing.com -- Clearside Biomedical Inc . (NASDAQ: CLSD) stock surged 51% after Health Canada approved the company’s XIPERE treatment for uveitic macular edema, expanding the medication’s ...

Continued Global Expansion and Validation of Clearside’s Suprachoroidal Space Injection Platform Featuring its Commercially Proven SCS Microinjector® - ALPHARETTA, Ga., July 23, 2025 (GLOBE NEWSWIRE) ...

Clearside’s innovative SCS Microinjector is being used in commercial ophthalmic products and promising clinical development programs by Aura Biosciences, Bausch + Lomb, BioCryst Pharmaceuticals, ...

The most talked about and market moving research calls around Wall Street are now in one place. Here are today's research ...

Three big catalysts are gearing up to hit the markets at month’s end. Matt Maley is going live this Sunday at 1 PM ET to reveal how he’s trading short-term setups across financials, tech, defense, and ...

Clearside Biomedical CLSD shares fell 25.4% to $0.45. The market value of their outstanding shares is at $46.7 million. Sonnet BioTherapeutics SONN stock fell 21.06% to $6.15.

Fintel reports that on July 18, 2025, Chardan Capital downgraded their outlook for Clearside Biomedical (NasdaqGM:CLSD) from Buy to Neutral. Analyst Price Forecast Suggests 832.20% Upside As of July ...

Investing.com - Stifel 将 Clearside Biomedical (NASDAQ: CLSD) 的评级从买入下调至持有，并将目标价从 8.00 美元大幅削减至 2.00 美元，原因是该公司面临严重的财务限制。根据 InvestingPro 公允价值分析，该股票在过去一周已暴跌 32%，市值为 4700 万美元，显示出被低估的迹象。

Congratulations to the student-athletes of Cornwall High School who qualified for scholar-athlete status for the 2024-25 school year.